These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging. Bains LJ, Baker JH, Kyle AH, Minchinton AI, Reinsberg SA. Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):957-65. PubMed ID: 19480975 [Abstract] [Full Text] [Related]
4. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability. Tozer GM, Prise VE, Wilson J, Cemazar M, Shan S, Dewhirst MW, Barber PR, Vojnovic B, Chaplin DJ. Cancer Res; 2001 Sep 01; 61(17):6413-22. PubMed ID: 11522635 [Abstract] [Full Text] [Related]
5. Potentiation of photodynamic therapy antitumor activity in mice by nitric oxide synthase inhibition is fluence rate dependent. Henderson BW, Sitnik-Busch TM, Vaughan LA. Photochem Photobiol; 1999 Jul 01; 70(1):64-71. PubMed ID: 10420844 [Abstract] [Full Text] [Related]
6. Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin. Baker JH, Kyle AH, Bartels KL, Methot SP, Flanagan EJ, Balbirnie A, Cran JD, Minchinton AI. PLoS One; 2013 Jul 01; 8(10):e76832. PubMed ID: 24204680 [Abstract] [Full Text] [Related]
7. Preferential action of arsenic trioxide in solid-tumor microenvironment enhances radiation therapy. Griffin RJ, Williams BW, Park HJ, Song CW. Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1516-22. PubMed ID: 15817358 [Abstract] [Full Text] [Related]
8. Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice. Durand RE, Olive PL. Radiat Oncol Investig; 1997 Apr 01; 5(5):213-9. PubMed ID: 9372543 [Abstract] [Full Text] [Related]
9. Combretastatin A-4 phosphate as a tumor vascular-targeting agent: early effects in tumors and normal tissues. Tozer GM, Prise VE, Wilson J, Locke RJ, Vojnovic B, Stratford MR, Dennis MF, Chaplin DJ. Cancer Res; 1999 Apr 01; 59(7):1626-34. PubMed ID: 10197639 [Abstract] [Full Text] [Related]
10. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia. Siim BG, Menke DR, Dorie MJ, Brown JM. Cancer Res; 1997 Jul 15; 57(14):2922-8. PubMed ID: 9230202 [Abstract] [Full Text] [Related]
11. Carbogen breathing after irradiation enhances the effectiveness of tirapazamine in SiHa tumors but not SCCVII tumors in mice. Minchinton AI, Tonn DA, Sutherland DP, Kyle AH. Radiat Res; 2002 Jul 15; 158(1):94-100. PubMed ID: 12071808 [Abstract] [Full Text] [Related]
12. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study. Aboagye EO, Dillehay LE, Bhujwalla ZM, Lee DJ. Radiat Oncol Investig; 1998 Jul 15; 6(6):249-54. PubMed ID: 9885940 [Abstract] [Full Text] [Related]
13. Oxygen dependence and extravascular transport of hypoxia-activated prodrugs: comparison of the dinitrobenzamide mustard PR-104A and tirapazamine. Hicks KO, Myint H, Patterson AV, Pruijn FB, Siim BG, Patel K, Wilson WR. Int J Radiat Oncol Biol Phys; 2007 Oct 01; 69(2):560-71. PubMed ID: 17869669 [Abstract] [Full Text] [Related]
14. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice. Olive PL, Vikse CM, Banath JP. Cancer Res; 1996 Oct 01; 56(19):4460-3. PubMed ID: 8813141 [Abstract] [Full Text] [Related]
15. Tirapazamine: hypoxic cytotoxicity and interaction with radiation as assessed by the micronucleus assay. Shibata T, Shibamoto Y, Sasai K, Oya N, Murata R, Takagi T, Hiraoka M, Takahashi M, Abe M. Br J Cancer Suppl; 1996 Jul 01; 27():S61-4. PubMed ID: 8763848 [Abstract] [Full Text] [Related]
16. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia. Aboagye EO, Maxwell RJ, Kelson AB, Tracy M, Lewis AD, Graham MA, Horsman MR, Griffiths JR, Workman P. Cancer Res; 1997 Aug 01; 57(15):3314-8. PubMed ID: 9242466 [Abstract] [Full Text] [Related]
17. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment. Alvarez V, Lodillinsky C, Umerez S, Sandes E, Eiján AM. Int J Mol Med; 2005 Oct 01; 16(4):565-71. PubMed ID: 16142388 [Abstract] [Full Text] [Related]
18. Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation. Shibata T, Shibamoto Y, Sasai K, Oya N, Murata R, Takagi T, Hiraoka M, Abe M. Jpn J Cancer Res; 1996 Jan 01; 87(1):98-104. PubMed ID: 8609056 [Abstract] [Full Text] [Related]
19. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats. Chen SX, Song T, Zhou SH, Liu YH, Wu SJ, Liu LY. Eur J Pharmacol; 2008 Apr 28; 584(2-3):368-75. PubMed ID: 18334254 [Abstract] [Full Text] [Related]
20. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma. Sun JR, Brown JM. Cancer Res; 1989 Oct 15; 49(20):5664-70. PubMed ID: 2790784 [Abstract] [Full Text] [Related] Page: [Next] [New Search]